I lead the Infectious Disease Epidemiology and Analytics (IDEA) G5 Unit in the Department of Global Health at Institut Pasteur. Our team uses inter-disciplinary research tools spanning mathematical models, epidemiological cohort studies, and multiplex assays to investigate the epidemiology of infectious diseases. A key goal is the development of multiplex assays and statistical tools for integrated surveillance of multiple pathogens. Despite this multi-pathogen focus, I have a special fondness for malaria and neglected tropical diseases, and my favourite parasite is definitely Plasmodium vivax. Like many other researchers, I have developed an interest in coronaviruses, and have made some small contributions in the development of novel serological assays.
Click to view graph
Connections
Click to view timeline
Timeline
About
Transversal Projects
Projects
Former Teams
Publications
Download-
2024Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study., Lancet Child Adolesc Health 2024 Aug; (): .
-
2024PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial., NPJ Vaccines 2024 Jan; 9(1): 10.
-
2023Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil., Lancet Reg Health Am 2023 Jun; 22(): 100511.
-
2023Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
-
2023Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
-
2022Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
-
2022Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project., Nat Commun 2022 Aug; 13(1): 4490.
-
2022Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
-
2022Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment., BMC Med 2022 03; 20(1): 98.
-
2021How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites., Malar J 2021 Dec; 20(1): 479.
-
+View full list of publications